Current Trials for Depression

The OARS-7 Study for Major Depressive Disorder

The purpose of the J&J OARS-7 Study is to evaluate a medication to treat depression (MDD)  and depression with insomnia (MDDIS). This study is for intended for people diagnosed with depression who have only experienced a partial response to their current antidepressant treatment; in other words, they are still currently experiencing symptoms of depression. The main goal of this study is to learn how safe the study drug is and how well the study drug works when taken with the antidepressants you are currently taking for depression.

What will I do if I participate?

There are two parts of this study. In part 1, participants will take part in 8 study visits in-person at Northwestern Hospital where they will be given either study drug or a placebo. After part one, participants may be offered the option to continue into part 2, which is an open-label phase (everyone receives study drug). Visits will include clinical assessments and questionnaires regarding mental health symptoms.

Eligibility Criteria

  • Open to ages 18-74.
  • Diagnosed with Major Depressive disorder, currently experiencing an episode of depression.
  • Must be stable on anti-depressants for 6 weeks, with inadequate improvement.

Not sure if you qualify? No problem, fill out the form below and our site will contact you.

Participate in a clinical trial for depression

Participate in a clinical trial for depression

Name
Name
First
Last
Have you been diagnosed with depression?
Are you currently taking any psychiatric medications?
What kind of clinical trial are you interested in? Select all that apply.
By checking this box, I consent to my entry being saved in the lab database. If permitted, my entry will also be stored in the site's web database and will remain confidential to site staff, regardless of eligibility.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.